Our Science

Our Science

Publications

Year

Cancer Research

February 21, 2024

Lipid-encapsulated mRNAs encoding complex fusion proteins potentiate anti-tumor immune responses

Cancer Cell

January 11, 2024

Clinical and Molecular Features of Acquired Resistance to Immunotherapy in Non-small Cell Lung Cancer

Frontiers in Immunology

September 19, 2023

Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists

European Journal of Cancer

April 5, 2023

Shining a LIGHT on myeloid cell targeted immunotherapy

The Journal of Immunology

September 22, 2022

Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D

The Journal of Immunology

July 11, 2022

LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade

Cancer Immunology Research

December 20, 2019

CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity

Journal for ImmunoTherapy of Cancer

January 25, 2019

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy